Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Nature Communications is interested in publishing high-quality clinical research in all areas of medicine. In this call for papers, we are inviting submissions of papers reporting interventional trials - we will consider phase I to phase IV clinical trials - including those yielding negative results for which primary end-points were not met.
We are particularly interested in studies first reporting primary and secondary outcomes of interventional clinical trials, but we would also consider long-term follow-up of published trials.
All manuscripts will be considered according to our editorial policies for clinical research. Further information can be found in our recent editorial. Unfortunately, we cannot guarantee that any individual paper will be included in the desired collection.